Atrial Fibrillation Associated Costs for Stroke Hospitalizations of Medicare Beneficiaries in the Stroke Belt of the United States.

نویسندگان

  • Guijing Wang
  • Xin Tong
  • Mary G George
چکیده

PURPOSE To estimate atrial fibrillation (AF)-associated costs for stroke hospitalizations among Medicare beneficiaries aged ≥65 years in a 11-state region called stroke belt in the United States. METHODS Using the 2010 Medicare Provider Analysis and Review File database, we analyzed costs of stroke hospitalizations conditional on presence of AF (n=226 289) after excluding those with subarachnoid hemorrhage, no information on race, or a length of stay [LOS] of 30 or more days. We employed regression analysis to estimate for defined subgroups the impact of AF on costs while controlling for major potential confounders. RESULTS The average cost of all stroke hospitalizations was $27 915. The presence of AF increased this cost by $2711 (9.4%; P<0.001). AF-associated costs were $3159, $2610, and $2197 for patients aged 65-74, 75-84, and ≥85 years, respectively (all P<0.001). Among hospitalization with a length of stay (LOS) of 14-29 days, AF increased the costs by $5888 (P<0.001). AF was not associated with higher costs for hospitalizations involving intracerebral hemorrhage. CONCLUSIONS The costs of stroke hospitalizations are high, and they are even higher if the patient has AF. Further information is needed on the costs in patients with AF who are taking anticoagulants.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

BACKGROUND AND PURPOSE More than 2 million Americans have atrial fibrillation, and without antithrombotic therapy, their stroke rate is increased 5-fold. In randomized controlled trials, warfarin prevented 65% of ischemic strokes (hazard ratio [HR], 0.35; 95% CI, 0.26 to 0.48) compared with no antithrombotic therapy. However, the effectiveness of warfarin therapy outside of clinical trials is u...

متن کامل

Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.

BACKGROUND AND PURPOSE in controlled trials, anticoagulation with warfarin reduces stroke risk by nearly two thirds, but the benefit has been less pronounced in clinical practice. This report describes the extent of warfarin use, its effectiveness, and its impact on medical costs among Medicare patients with nonvalvular atrial fibrillation. METHODS using claims from >2 million beneficiaries i...

متن کامل

The Prevalence of Prescription of New Anticoagulant Drugs and Its Determinant Factors in Patients With Ischemic Stroke and Non-valvular Atrial Fibrillation

Background: Patients with ischemic stroke and underlying Atrial Fibrillation (AF) have a high risk of recurrent embolic events. New Oral Anticoagulant (NOAC) is highly effective and reduces the risk of recurrence in AF-associated Ischemic Stroke (AFAIS). Objectives: This study aimed to determine the prescription pattern of NOAC and its determinant factors in patients with non-valvular AFAIS. ...

متن کامل

Transcranial Doppler application for risk assessment of stroke in patients with mechanical mitral valve

Introduction: Observing microembolic signals in brain vessels by transcranial Doppler technology is a very common finding in patients with mechanical heart valve. These signals are almost always clinically asymptomatic. The aim of this study was assessment of transcranial Doppler in detecting probability of stroke in patients with mechanical heart valve. Methods: This descriptive study was ca...

متن کامل

Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation.

BACKGROUND AND PURPOSE Antithrombotic therapy can prevent strokes and transient ischemic attacks (TIAs) in carefully selected patients who have chronic nonvalvular atrial fibrillation (NVAF). Our objectives were 3-fold: to document the use of warfarin and aspirin therapy in Missouri Medicare beneficiaries with chronic NVAF; to identify factors associated with warfarin and aspirin underuse; and ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of atrial fibrillation

دوره 5 6  شماره 

صفحات  -

تاریخ انتشار 2013